Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173019 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173016 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2022-10-28 | 2022-12-08 | 173010 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2022-10-28 | 2023-01-18 | 173000 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-10-17 | 2023-06-09 | 172030 |
TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-17 | 2023-07-28 | 172027 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-17 | 2022-12-08 | 172021 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2022-10-17 | 2023-01-12 | 172013 |
TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170795 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |